day 1 agenda

7th Edition of Innovations and State of the Art in ALZHEIMER'S & DEMENTIA on Sep 07-08, 2026 at Paris, France
Day -1(Sep 07, 2026)
Tentative Program
09:00-09:30	KeynoteTalk: ACE-dependent Alzheimer’s disease (AD)
	Sergei M. Danilov, University of Illinois, USA
09:30-10:00	Slot Available
10:00-10:30	KeynoteTalk: Glomerular (mesangial) amyloidogenesis in AL (light chain-associated) amyloidosis: Translational studies with implications for further treatment modalities. Similarities with amyloid formation in Alzheimer disease
	Guillermo A. Herrera , University of South Alabama, USA
Group Photo & Refreshment Break (10:30-10:50)
Technical session-I
10:50-11:10	Obtaining personalized predictions from a randomized controlled trial on Alzheimer’s disease
	Dennis Shen, University of Southern California, USA
11:10-11:30	The Traumatic brain injury and the risk of dementia
	Wendy Lin, University of British Columbia, Canada
11:30-11:50	Slot Available
11:50-12:10	Nonhuman Primate Models of Alzheimer’s Disease And Parkinson’sDisease Co-pathologies
	Jeffrey H. Kordower, Arizona State University, USA
12:10-12:30	Relationships among tau, amyloid, neuroinflammation, NMDA receptors and cognitive performance are strongly modulated by sex
	Anat Biegon, University of Uppsala, Sweden
12:30-12:50	Intermittent hypoxia training attenuates brain atrophy in elderly adultswith mild cognitive impairment
	Xiangrong Shi, University of North Texas Health Science Centre, USA
12:50-13:10	Slot Available
Lunch Break @ Restaurant (13:10-14:00)
Technical session-II
14:00-14:20	Arterial Tortuosity as a Marker of Cerebrovascular Aging and Dementia Risk
	Yulin Ge, NYU Grossman School of Medicine, USA
14:20-14:40	Electroacupuncture reshapes the microbial composition, co-occurrence network modules and predictive metabolic pathways related to the behavioral and psychological symptoms of dementia in Alzheimer’s disease
	Fu-You Su, Guangzhou University of Chinese Medicine, China
14:40-15:00	Gut virome signatures and bacteriophage–bacterial interactions in amyloid-positive Alzheimer’s disease
	Mahin Ghorbani, Karolinska Institutet, Sweden
15:00-15:20	Slot Available
15:20-15:40	Stepwise identification of prodromal dementia: testing a practical model for primary care
	Boaz Levy, University of Massachusetts Boston, USA
15:40-16:00	Cortical neuron dysfunction in AD brain at early-stage without beta-amyloid aggregation
	Xiu-Ti Hu, Rush University Medical Center, USA
Refreshment Break(16:00-16:10)
Note: This is a Tentative program, subjects and timings will changes.
Day-1 Concludes